A faster progression and deterioration in disease course in GBA1-PD patients has been reported extensively in literature, concomitant with a reduced survival rate, compared to iPD (Winder-Rhodes et al. 2013; Brockmann et al. 2015). The gene discussed is GBA1; the disease is Parkinson disease.